Abstract: Owing to their high surface area and porosity, metal-organic frameworks (MOFs) have been gradually employed for a myriad of applications ranging from sensing, pollutant adsorption, and drug delivery to environmental remediation and catalysis. Magnetic nanoparticles-metal-organic frameworks (MMOFs) hybrid materials can facilitate facile removal of MOFs from solutions. In this report, we report the synthesis of Fe 3 O 4 @UiO-66 by encapsulation and simulated the drug loading and release by studying the adsorption and release of AO7. Thus, we loaded these MMOFs with AO7 and found that they were able to trigger and control its release by simply applying an external magnetic field. The magnetic field heats the magnets in the MOF, which causes the load to burst from the framework.
Introduction
Magnetic metal-organic frameworks [1] (MMOFs), comprising of magnetic nanoparticles and MOFs [2] [3] [4] , have attracted tremendous of interests from researchers in the past decade [5, 6] . Such materials have the benefits of the nanocharacteristics of MOFs, which in turn allows for expanding the scope of MOFs' applications. Such active nanoparticles include quantum dots [7] , metal nanoparticles/nanorods [8] , graphene [9, 10] , porous silica nanoparticles [11, 12] , and magnetic beads [13] , which have been applied in catalysis, optics, sensing, liquid phase separation and adsorption, etc. [14] . MMOFs have the following advantages: (I) the application of MMOFs is enhanced through selecting a suitable target material, and the regulation of synthesis conditions can yield materials for specific applications (such as catalysis, adsorption, and release) [15] . (II) It overcomes the shortcomings of the simple magnetic particles' lack of selectivity and the accumulation in the magnetic variation. The rate of diffusion and mass transfer characteristics can 
Experiment

Materials
All chemicals and reagents used were of analytical grade. Ferric chloride hexahydrate (FeCl3·6H2O) was purchased from Chengdu kelong chemical reagent plant (Chengdu, China). Iron (II) dichloride tetrahydrate (FeCl2·4H2O) was purchased from Tianjin Guangfu fine chemical research institute (Tianjin, China). Zirconium (IV) chloride (ZrCl4) was purchased from Aladdin (Aladdin Industrial Cooperation, Shanghai, China). Terephthalic acid, N,N-Dimethylformamidel, ammonium hydroxide, thioglycolic acid, polyethylene glycol, and Orange Ⅱ sodium salt (AO7) were purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai , China).
Synthesis of Samples
Synthesis of Fe3O4 Fe3O4 nanoparticles were synthesized in accord to a reported procedure [35] . Ferric chloride hexahydrate (2.43 g), iron dichloride tetrahydrate (1.19 g), and polyethylene glycol (1.00 g) were dissolved in 100 mL deionized water under N2 atmosphere. Ammonium hydroxide was added to the solution with stirring until the pH reached 11. Then, the solution was stirred for 30 min at 50 °C, follow by sonication for 30 min before being heated to 80 °C for 1 h. The precipitation was separated by magnetism and washed with distilled water until neutral. Finally, the product was dried under vacuum for 4 h.
Synthesis of Fe3O4-MAA The deposition of Fe3O4 (0.50 g) was dispersed in 50 mL mercaptoacetic acid (MAA) solution (2.9 mmol) in ultrasound for 15 min, and then the solution was stirred for 24 h at room temperature [36] . The particle was washed with ethanol and deionized water respectively with the help of magnet, and then dried in vacuum oven for 4 h.
Synthesis of Fe3O4@UiO-66 We synthesized Fe3O4@UiO-66 according to the literature [37] . Briefly, 0.05 g Fe3O4-MAA was dispersed in 58 mL DMF, and then 0.12 g ZrCl4 and 0.134 g H2BDC were added. The mixture was in ultrasound for 20 min. Then, the solution was mechanically stirred for 24 h at 120 °C. The sample was washed by DMF and ethanol, respectively. The ultimate product was dried in vacuum at 90 °C. 
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All chemicals and reagents used were of analytical grade. Ferric chloride hexahydrate (FeCl 3 ·6H 2 O) was purchased from Chengdu kelong chemical reagent plant (Chengdu, China). Iron (II) dichloride tetrahydrate (FeCl 2 ·4H 2 O) was purchased from Tianjin Guangfu fine chemical research institute (Tianjin, China). Zirconium (IV) chloride (ZrCl 4 ) was purchased from Aladdin (Aladdin Industrial Cooperation, Shanghai, China). Terephthalic acid, N,N-Dimethylformamidel, ammonium hydroxide, thioglycolic acid, polyethylene glycol, and Orange II sodium salt (AO7) were purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai , China).
Synthesis of Samples
Synthesis of Fe 3 O 4 Fe 3 O 4 nanoparticles were synthesized in accord to a reported procedure [35] . Ferric chloride hexahydrate (2.43 g), iron dichloride tetrahydrate (1.19 g), and polyethylene glycol (1.00 g) were dissolved in 100 mL deionized water under N 2 atmosphere. Ammonium hydroxide was added to the solution with stirring until the pH reached 11. Then, the solution was stirred for 30 min at 50 • C, follow by sonication for 30 min before being heated to 80 • C for 1 h. The precipitation was separated by magnetism and washed with distilled water until neutral. Finally, the product was dried under vacuum for 4 h. Synthesis of Fe 3 O 4 -MAA The deposition of Fe 3 O 4 (0.50 g) was dispersed in 50 mL mercaptoacetic acid (MAA) solution (2.9 mmol) in ultrasound for 15 min, and then the solution was stirred for 24 h at room temperature [36] . The particle was washed with ethanol and deionized water respectively with the help of magnet, and then dried in vacuum oven for 4 h.
Synthesis of Fe 3 O 4 @UiO-66
We synthesized Fe 3 O 4 @UiO-66 according to the literature [37] . Briefly, 0.05 g Fe 3 O 4 -MAA was dispersed in 58 mL DMF, and then 0.12 g ZrCl 4 and 0.134 g H 2 BDC were added. The mixture was in ultrasound for 20 min. Then, the solution was mechanically stirred for 24 h at 120 • C. The sample was washed by DMF and ethanol, respectively. The ultimate product was dried in vacuum at 90 • C.
Adsorption and Release Experiment
The adsorption experiments were executed at 37 • C. Ten mg samples were added to a series of AO7 solutions with concentrations of 10, 20, 30, and 40 ppm (50 mL) to measure the adsorption kinetics. The amount of AO7 in solution was monitored by UV-vis spectrometry by using a calibration curve based on the Lambert-Beer law:
where A is the absorbance and C t is the concentration of AO7 solution (mg/L). Then, the amount of the absorbed dye: q t (mg/g) was calculated by the following equation:
where C 0 is the initial concentration of the solution (mg/L); C t is the concentration of the solutions at time (t); V 0 is the volume of the solution (mL); m is the mass of the adsorbent (g). Adsorbed Fe 3 O 4 @UiO-66 with loaded AO7 was treated with methanol under circumstance of 37 • C. Five mg different concentrations of adsorbed Fe 3 O 4 @UiO-66 was respectively added to 20 mL methanol to study the release of AO7.
Characterization
Morphology was collected by a field emission scanning electron microscope (SEM) JSM7100F (Hitachi, Tokyo, Japan).
Powder X-ray diffraction (PXRD) patterns were obtained using a Rigaku X-ray Diffractometer Model D/MAX-IIIC (Bruker, Billerica, MA, Germany). Measurements were made over a range of 4 • < 2θ < 40 • in 0.02 step size at a scanning rate of 10 deg/min.
Fourier transform infrared spectroscopy (FT-IR) spectra of products were recorded on NICOLET iS50 FT-IR spectrometer (Thermo Fisher, Waltham, MA, USA).
The magnetic properties were characterized over a range of 0~1.5 T under room temperature by a multi-function vibrating sample magnetometer (VSM) JDAW-2000D (Yingpu, Changchun, China).
V-Sorb 2800 TP surface area and pore size analyzer (GAPP, Beijing, China) was used to measure the N2 adsorption-desorption isotherms of samples at 77 K.
The absorbance measurements of all AO7 aqueous solution were performed on a TU-1810DSPC UV-vis spectrometer (Beijing Purkinje General Instrument Co., Ltd., Beijing, China). [38] . The adsorption bands of symmetric and anti-symmetric stretching vibration at 2923 cm −1 and 2853 cm −1 correspond to C-H observed for in curve b, which represents the presence of the carbon hydrogen bonds of thioglycolic acid. And the peaks at 1618 cm −1 and 3380 cm −1 represent the carboxyl group and the water. Comparing curve b with curve a, we see that mercaptoacetic acid has been successfully received on Fe 3 O 4 . In curve c, the characteristic absorption bands of N-H in DMF emerged at 1656 cm −1 . Moreover, the symmetric and anti-symmetric stretching vibration peaks of carboxyl groups were at 1585 cm −1 and 1398 cm −1 , and at 746 cm −1 , the characteristic vibration of Zr-O emerged [37] , confirming the presence of UiO-66, and verifying the successful complexation of UiO-66 and Fe 3 O 4 . Our results show that the method of modifying Fe 3 O 4 with thioglycolic acid is feasible.
Results and Discussion
To confirm the structural integrity of the UiO-66 contained in Fe 3 O 4 @UiO-66, the PXRD of the composite material was collected and compared with the simulation of UiO-66 ( Figure 2c ). As can be seen from Figure 2d , comparison of the composite with the simulation showed that the crystal diffraction peak is visible and consistent with the simulation. This provides evidence for practicality of the preparation of porous composite materials involving Fe 3 O 4 modified by MAA as the crystal nucleus in precursor UiO-66 solution. As shown in Figure 3 , to evaluate the magnetic properties of Fe3O4@UiO-66, the magnetic measurements were performed in a magnetic field range from −15 to +15 kOe at room temperature. The saturation magnetization of the Fe3O4@UiO-66 was 6.51 emu/g, smaller than that of the pristine Fe3O4 nanoparticles (70.31 emu/g) due to the encapsulation within the UiO-66 layer. Both curves present a magnetic hysteresis loop (Figure 3) , which demonstrated the strong superparamagnetic character of the as-synthesized Fe3O4@UiO-66 composites. Furthermore, it is convenient to control the location of separation and release after absorption. Finally, from the video (Supplementary Materials) we can see that the Fe3O4@UiO-66 solution could be quickly collected using the magnet. Because of which, Fe3O4@UiO-66 can be magnetically recovered and the cost is relatively reduced. As shown in Figure 3 , to evaluate the magnetic properties of Fe 3 O 4 @UiO-66, the magnetic measurements were performed in a magnetic field range from −15 to +15 kOe at room temperature. The saturation magnetization of the Fe 3 O 4 @UiO-66 was 6.51 emu/g, smaller than that of the pristine Fe 3 O 4 nanoparticles (70.31 emu/g) due to the encapsulation within the UiO-66 layer. Both curves present a magnetic hysteresis loop (Figure 3) , which demonstrated the strong superparamagnetic character of the as-synthesized Fe 3 O 4 @UiO-66 composites. Furthermore, it is convenient to control the location of separation and release after absorption. Finally, from the video (Supplementary Materials) we can see that the Fe 3 O 4 @UiO-66 solution could be quickly collected using the magnet. Because of which, Fe 3 O 4 @UiO-66 can be magnetically recovered and the cost is relatively reduced. As shown in Figure 3 , to evaluate the magnetic properties of Fe3O4@UiO-66, the magnetic measurements were performed in a magnetic field range from −15 to +15 kOe at room temperature. The saturation magnetization of the Fe3O4@UiO-66 was 6.51 emu/g, smaller than that of the pristine Fe3O4 nanoparticles (70.31 emu/g) due to the encapsulation within the UiO-66 layer. Both curves present a magnetic hysteresis loop (Figure 3) , which demonstrated the strong superparamagnetic character of the as-synthesized Fe3O4@UiO-66 composites. Furthermore, it is convenient to control the location of separation and release after absorption. Finally, from the video (Supplementary Materials) we can see that the Fe3O4@UiO-66 solution could be quickly collected using the magnet. Because of which, Fe3O4@UiO-66 can be magnetically recovered and the cost is relatively reduced. As illustrated in Figure 4 , the BET surface area and pore distribution were calculated from the N 2 adsorption isotherms measured at 77 K. The original UiO-66 has a larger surface area (793 m 2 /g) than Fe 3 As illustrated in Figure 4 , the BET surface area and pore distribution were calculated from the N2 adsorption isotherms measured at 77 K. The original UiO-66 has a larger surface area (793 m 2 /g) than Fe3O4@UiO-66 (429 m 2 /g) due to the encapsulation, as shown at Figure 4a ,b. As a result of the core-shell structure of Fe3O4@UiO-66, Fe3O4 particles were wrapped in UiO-66, thus giving rise to the pore volume increases. Fe3O4 particles occupied the channel, accounting for large volume but low available volume. As indicated in Figure 4c ,d, UiO-66 and the composite Fe3O4@UiO-66 are all mesoporous materials. As shown in Figure 5a , the adsorption of Fe3O4@UiO-66 with a very fast growth rate was complete within 5 h, and with the passage of time, the adsorption rate of Fe3O4@UiO-66 slowed down and reached a plateau at 140 mg/g. AO7 [39, 40] is an acidic dye, the composite mainly relies on Lewis acid-base interaction between AO7 and Zr-based MOFs [34] . Figure 5c shows the release profile of Fe3O4@UiO-66 with AO7, which is quite fast and releases 60% within 5 h which is affected by natural diffusion [34, 41] . The presence of methanol promotes the decomposition of Fe3O4@UiO-66 and the dye, accelerating the rate of dye release. Current environmental awareness is gradually changing attitudes and regulations, such as the new drug removal/release regulations (magnetic MOF for AO7), and are gradually beginning to reverse the situation. Compared with Figure 5a -d, although the adsorption capacity of UiO-66 and Fe3O4@UiO-66 is approximate, regarding the release rate, Fe3O4@UiO-66 is faster than UiO-66 in the initial release. These findings go against our hypothesis that the magnetic field heats the magnets in the MOF, which causes the load to burst from the framework.
AO7 is an acidic dye with benzene. Meanwhile, aspirin is a similar acid medication used as a painkiller and Iressa is a small molecule with benzene for the treatment of tumors. Due to the magnetic control of Fe3O4@UiO-66, the drug-loaded composite can be targeted to release the drug in the human. Body fluids in humans are predominantly neutral or weakly basic, which slightly slows the rate of drug release. That means drugs will be released more slowly in the human body, which will be more beneficial to drugs being absorbed by the body. As shown in Figure 5a , the adsorption of Fe 3 O 4 @UiO-66 with a very fast growth rate was complete within 5 h, and with the passage of time, the adsorption rate of Fe 3 O 4 @UiO-66 slowed down and reached a plateau at 140 mg/g. AO7 [39, 40] is an acidic dye, the composite mainly relies on Lewis acid-base interaction between AO7 and Zr-based MOFs [34] . Figure 5c shows the release profile of Fe 3 O 4 @UiO-66 with AO7, which is quite fast and releases 60% within 5 h which is affected by natural diffusion [34, 41] . The presence of methanol promotes the decomposition of Fe 3 O 4 @UiO-66 and the dye, accelerating the rate of dye release. Current environmental awareness is gradually changing attitudes and regulations, such as the new drug removal/release regulations (magnetic MOF for AO7), and are gradually beginning to reverse the situation. Compared with Figure 5a -d, although the adsorption capacity of UiO-66 and Fe 3 O 4 @UiO-66 is approximate, regarding the release rate, Fe 3 O 4 @UiO-66 is faster than UiO-66 in the initial release. These findings go against our hypothesis that the magnetic field heats the magnets in the MOF, which causes the load to burst from the framework.
AO7 is an acidic dye with benzene. Meanwhile, aspirin is a similar acid medication used as a painkiller and Iressa is a small molecule with benzene for the treatment of tumors. Due to the magnetic control of Fe 3 O 4 @UiO-66, the drug-loaded composite can be targeted to release the drug in the human. Body fluids in humans are predominantly neutral or weakly basic, which slightly slows the rate of drug release. That means drugs will be released more slowly in the human body, which will be more beneficial to drugs being absorbed by the body. 
Conclusions
In summary, we have synthesized Fe3O4@UiO-66 by encapsulating Fe3O4 into UiO-66. The incorporation of magnetic Fe3O4 enables facile removal of adsorbent. The dye was adsorbed and released at 37 °C, the Fe3O4@UiO-66 composite material was found to have an approximate loading capacity (140 mg/g) comparable to the conventional UiO-66 (140 mg/g) and the release rate of the dye under the action of methanol are also considerable. By comparing the properties and structure of AO7 with similar drugs, we think some drugs such as Aspirin and Iressa can also be adsorbed by Fe3O4@UiO-66. Because of the effect of pH on drug release, the rate of release is somewhat slowed down, which ensures that the drug is better absorbed by the body. Some promising applications in industrial sustainability, medical processes, and environment-related areas are also discussed.
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Video: Fe3O4@UiO-66 dispersion in the presence of a magnet field.
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